Overview

• Around 55,000 people in Spain live with multiple sclerosis and about 2,000 new cases are diagnosed each year, with women aged 20 to 40 accounting for three-quarters of relapsing-remitting patients.
• Symptoms can vary widely—from vision loss and vertigo to fatigue and cognitive impairment—often causing delays of years before a correct diagnosis.
• Wider access to MRI and updated diagnostic criteria are driving earlier identification of the disease, particularly in younger adults.
• Since the first treatment in 1995, clinicians have approved 16 pharmaceutical therapies, allowing more personalized care plans and improved outcomes.
• Associations such as the Asociación Granadina de Esclerosis Múltiple play a vital role by offering rehabilitation services, psychological support and community workshops.